Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127405881 | 12740588 | 1 | I | 2015 | 20160906 | 20160914 | 20160914 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-073774 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 68.40000 | KG | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127405881 | 12740588 | 1 | PS | SPRYCEL | DASATINIB | 1 | Unknown | U | 21986 | FILM-COATED TABLET | |||||||||
| 127405881 | 12740588 | 2 | SS | BOSULIF | BOSUTINIB MONOHYDRATE | 1 | Unknown | 500 MG, UNK | N29036 | 0 | 500 | MG | |||||||
| 127405881 | 12740588 | 3 | SS | TRAMADOL. | TRAMADOL | 1 | Oral | 50 MG, UNK | U | 0 | 50 | MG | BID | ||||||
| 127405881 | 12740588 | 4 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, UNK | 0 | 25 | MG | QD | |||||||
| 127405881 | 12740588 | 5 | C | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | 1 | Unknown | 2 MG, UNK | 0 | 2 | MG | CAPSULE | BID | ||||||
| 127405881 | 12740588 | 6 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 18 MG, QD | U | 0 | 18 | MG | TABLET | QD | |||||
| 127405881 | 12740588 | 7 | C | METOCLOPRAM | METOCLOPRAMIDE | 1 | Oral | 5 MG, UNK | 0 | 5 | MG | TABLET | BID | ||||||
| 127405881 | 12740588 | 8 | C | NITROSTAT | NITROGLYCERIN | 1 | Oral | 0.4 MG, PRN | U | 0 | .4 | MG | TABLET | ||||||
| 127405881 | 12740588 | 9 | C | BABY ASPIRIN | ASPIRIN | 1 | Unknown | 81 MG, QD | U | 0 | 81 | MG | TABLET | QD | |||||
| 127405881 | 12740588 | 10 | C | INVOKANA | CANAGLIFLOZIN | 1 | Oral | 100 MG, QD | U | 0 | 100 | MG | TABLET | QD | |||||
| 127405881 | 12740588 | 11 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | TABLET | QD | |||||
| 127405881 | 12740588 | 12 | C | ACETAMINOPHEN AND CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | 1 DF, UNK | U | 0 | 1 | DF | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127405881 | 12740588 | 1 | Product used for unknown indication |
| 127405881 | 12740588 | 2 | Leukaemia |
| 127405881 | 12740588 | 3 | Pain |
| 127405881 | 12740588 | 4 | Blood pressure measurement |
| 127405881 | 12740588 | 5 | Product used for unknown indication |
| 127405881 | 12740588 | 6 | Product used for unknown indication |
| 127405881 | 12740588 | 7 | Product used for unknown indication |
| 127405881 | 12740588 | 8 | Chest pain |
| 127405881 | 12740588 | 9 | Product used for unknown indication |
| 127405881 | 12740588 | 10 | Product used for unknown indication |
| 127405881 | 12740588 | 11 | Product used for unknown indication |
| 127405881 | 12740588 | 12 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127405881 | 12740588 | OT |
| 127405881 | 12740588 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127405881 | 12740588 | Neuropathy peripheral | |
| 127405881 | 12740588 | Pancreatic disorder | |
| 127405881 | 12740588 | Pulmonary oedema | |
| 127405881 | 12740588 | Thyroid disorder | |
| 127405881 | 12740588 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127405881 | 12740588 | 2 | 2015 | 0 |